Investing.com - Financial Markets Worldwide
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

IRIDEX Corporation (IRIX)

NASDAQ
Currency in USD
1.720
-0.020(-1.15%)
Closed
IRIX Scorecard
Full Analysis
Quickly burning through cash
Fair Value
Unlock Value
Day's Range
1.7101.800
52 wk Range
1.2723.650
Key Statistics
Edit
Prev. Close
1.74
Open
1.796
Day's Range
1.71-1.8
52 wk Range
1.272-3.65
Volume
15.8K
Average Volume (3m)
32.2K
1-Year Change
-37.63%
Book Value / Share
0.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IRIX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
pro lock
Unlock All 7
Analysts do not anticipate the company will be profitable this year
Unlock InvestingPro

IRIDEX Corporation News & Analysis

Show more

IRIDEX Corporation Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
111
Market
United States

Compare IRIX to Peers and Sector

Metrics to compare
IRIX
Peers
Sector
Relationship
P/E Ratio
−2.6x−2.8x−0.7x
PEG Ratio
0.070.220.00
Price/Book
10.9x2.6x2.6x
Price / LTM Sales
0.6x2.1x3.2x
Upside (Analyst Target)
14.9%44.4%47.1%
Fair Value Upside
Unlock3.6%7.3%Unlock

FAQ

What Is the IRIDEX (IRIX) Stock Price Today?

The IRIDEX stock price today is 1.72

What Stock Exchange Does IRIDEX Trade On?

IRIDEX is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for IRIDEX?

The stock symbol for IRIDEX is "IRIX."

What Is the IRIDEX Market Cap?

As of today, IRIDEX market cap is 28.86M.

What is IRIDEX Earnings Per Share?

The IRIDEX EPS is -0.675.

What Is the Next IRIDEX Earnings Date?

IRIDEX will release its next earnings report on 05 Mar 2025.

From a Technical Analysis Perspective, Is IRIX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.